For the vast majority of people, idiopathic thrombocytopenic purpura (ITP) is not deadly. Most children recover completely, and most adults live a normal lifespan with monitoring or treatment. The real danger is serious bleeding, especially bleeding in the brain, which is rare and mainly occurs when the platelet count is very low. Knowing your count, the warning signs, and when to seek help is what keeps ITP safe.
“Is ITP deadly?” is one of the first questions patients ask me after diagnosis. Below I explain what ITP is, who is at risk of serious complications, how it is diagnosed and treated, and what the outlook really looks like.
What Is ITP?
ITP is an autoimmune condition in which the immune system makes antibodies that attack platelets, the small cell fragments that help blood clot. The spleen removes the antibody-coated platelets, and the immune attack can also reduce platelet production in the bone marrow. The result is a low platelet count, known as thrombocytopenia.
Doctors now often call it immune thrombocytopenia, because the immune cause is well understood and many patients have no purple skin marks (purpura). ITP is defined as a platelet count below 100 × 10^9/L with no other cause found. A normal count is about 150–450 × 10^9/L.
Children versus adults
In children, ITP often appears suddenly a few weeks after a viral infection and usually resolves on its own within months. In adults it tends to develop more gradually and is more likely to become chronic, meaning it lasts longer than 12 months.
| Phase | Duration since diagnosis |
|---|---|
| Newly diagnosed ITP | Up to 3 months |
| Persistent ITP | 3 to 12 months |
| Chronic ITP | More than 12 months |
Is ITP Deadly? Understanding the Real Risk
Death from ITP is uncommon. The risk comes almost entirely from severe bleeding, and that risk is closely linked to the platelet count and to other factors such as age.
| Platelet count (× 10^9/L) | What it usually means |
|---|---|
| 150–450 | Normal range |
| 50–100 | Usually no bleeding symptoms; often just monitored |
| 30–50 | Bruising possible; serious bleeding uncommon |
| 10–30 | Easy bruising, petechiae, nosebleeds; treatment often considered |
| Below 10 | Highest risk of serious or internal bleeding |
The most feared complication is intracranial hemorrhage, bleeding inside the skull. It is rare, but it can be life-threatening. Risk is higher in older adults, people with very low counts, those who have had previous major bleeding, and anyone also taking blood thinners or anti-inflammatory painkillers.
Other complications include heavy menstrual bleeding, gastrointestinal bleeding, and fatigue. The link between low platelet count and fatigue is real and often underestimated. Some treatments carry their own risks, such as infection after splenectomy or side effects from long-term steroids.
The overall outlook
For most patients, the long-term picture is reassuring. Children usually recover fully, and adults with chronic ITP generally have a life expectancy close to that of people without it, particularly when counts are kept in a safe range. Some adults go into spontaneous remission even years after diagnosis. The key to staying safe is regular follow-up, a clear plan for bleeding symptoms, and avoiding medicines that add to bleeding risk.
Symptoms of ITP
Many people with mild ITP have no symptoms and are diagnosed on a routine blood test. When symptoms occur, they reflect bleeding into the skin and mucous membranes:
- Easy or unexplained bruising
- Petechiae: tiny red or purple pinpoint spots, often on the lower legs
- Nosebleeds or bleeding gums
- Prolonged bleeding from cuts
- Heavy menstrual periods
- Blood blisters inside the mouth (“wet purpura”), which can signal a higher bleeding risk
- Blood in urine or stool, which needs prompt attention
How ITP Is Diagnosed
ITP is a diagnosis of exclusion: doctors confirm it by ruling out other causes of thrombocytopenia. The work-up usually includes:
- A complete blood count showing isolated low platelet levels, with normal red and white cells
- A blood film to confirm the low count is genuine and to look for abnormal cells
- Tests for infections such as HIV and hepatitis C, and sometimes H. pylori
- A review of medications that can lower platelets
A bone marrow examination is not needed for typical ITP. It is considered when features are atypical, when patients are older, or when treatment fails, to exclude bone marrow disorders such as myelodysplasia or leukemia.
Treatment Options
The goal of treatment is a safe platelet count, not a normal one. Many adults with counts above about 30 × 10^9/L and no bleeding need only monitoring. Treatment decisions also consider lifestyle, upcoming surgery, and patient preference.
First-line treatment
- Corticosteroids such as prednisone or dexamethasone dampen the immune attack and often raise platelets within days to weeks.
- Intravenous immunoglobulin (IVIG) raises platelets quickly and is used for bleeding or before procedures.
Second-line treatment
- Thrombopoietin receptor agonists (eltrombopag, romiplostim, avatrombopag) stimulate the marrow to make more platelets.
- Rituximab, an antibody that depletes the B cells making anti-platelet antibodies.
- Fostamatinib, an oral drug that reduces platelet destruction.
- Splenectomy, removal of the spleen, which can give lasting remission but is now used less often and requires vaccination against certain infections.
Emergency treatment
For life-threatening bleeding, doctors combine high-dose steroids, IVIG, and platelet transfusions. Transfused platelets are destroyed quickly in ITP, so they are reserved for emergencies; our article on platelet transfusion in ITP management explains why.
Everyday precautions
Avoid aspirin and anti-inflammatory painkillers such as ibuprofen, which impair platelet function. People with low counts should avoid contact sports and discuss any planned surgery or dental work with their hematologist. For more on platelet disorders, see our platelets guide.
Frequently Asked Questions
Can you live a normal life with ITP?
Yes. Most people with ITP, including chronic ITP, work, travel, exercise, and have families. The main adjustments are regular blood tests, avoiding certain medicines, and knowing when to seek help.
Does ITP turn into leukemia?
No. ITP is an autoimmune disorder, not a cancer, and it does not transform into leukemia. Occasionally a different condition is misdiagnosed as ITP at first, which is why atypical cases are investigated further.
Will my child’s ITP go away?
In most children, yes. Childhood ITP usually resolves within weeks to months, often without treatment. A minority develop chronic ITP, which is managed much as it is in adults.
What platelet count is dangerous?
Serious bleeding becomes more likely below about 20 × 10^9/L and especially below 10 × 10^9/L. However, symptoms and personal risk factors matter as much as the number, so your hematologist will interpret your count in context.
When to See a Doctor
See a doctor if you notice unexplained bruising, petechiae, or frequent nosebleeds. Seek emergency care immediately for a severe or sudden headache, confusion, vision changes, vomiting blood, black or bloody stools, or bleeding that will not stop, as these can signal dangerous bleeding. Working with a specialist in hematology gives you a clear plan for these situations.
